Loss of function and impaired degradation of a cataract-associated mutant connexin50.
A mutant human connexin50 (hCx50), hCx50P88S, has been linked to cataracts inherited as an autosomal dominant trait. The functional, biochemical and cellular behavior of wild-type and mutant hCx50 were examined in transfected cells. hCx50P88S was unable to induce gap junctional currents by itself, and it abolished gap junctional currents when co-expressed with wild-type (wt) hCx50. Cells transfected with hCx50P88S showed cytoplasmic accumulations of Cx50 immunoreactivity in addition to staining at appositional membranes; these accumulations did not significantly co-localize with markers for the endoplasmic reticulum, Golgi apparatus, lysosomes, endosomes or vimentin filaments. Immunoelectron microscopy studies localized hCx50P88S to cytoplasmic membrane stacks in close vicinity to the endoplasmic reticulum. In contrast, aggresome-like accumulations were induced by treatment of wt hCx50-transfected cells with proteasomal inhibitors. The formation of hCx50P88S accumulations in transiently transfected cells was not blocked by treatment with Brefeldin A suggesting that they form before Cx50 transits through the Golgi apparatus to the plasma membrane. Treatment of HeLa-hCx50P88S cells with cycloheximide demonstrated the presence of a very stable pool of hCx50P88S. Taken together, these results suggest that the P to S mutation at amino acid residue 88 causes a defect that leads to decreased degradation and subsequent accumulation of hCx50P88S in a cellular structure different from aggresomes.
Berthoud
Viviana M
VM
Department of Pediatrics, Section of Hematology/Oncology, University of Chicago, Chicago, IL 60637, USA. vberthou@peds.bsd.uchicago.edu
Minogue
Peter J
PJ
Guo
Jun
J
Williamson
Edward K
EK
Xu
Xiaorong
X
Ebihara
Lisa
L
Beyer
Eric C
EC
D000818:Animals; D002386:Cataract / Q000235:genetics*; D002460:Cell Line; D017630:Connexins; D004594:Electrophysiology; D005136:Eye Proteins / Q000235:genetics* / Q000378:metabolism; D006367:HeLa Cells / Q000648:ultrastructure; D006801:Humans; D015151:Immunoblotting; D008854:Microscopy, Electron; D009154:Mutation; D009842:Oligopeptides / Q000494:pharmacology; D010654:Phenylbutyrates / Q000494:pharmacology; D021381:Protein Transport / Q000187:drug effects; D014162:Transfection; D000099264:Connexin 50
D017630:Connexins; D005136:Eye Proteins; D009842:Oligopeptides; D010654:Phenylbutyrates; D000099264:Connexin 50; C075773:4-phenylbutyric acid; C078846:epoxomicin